177-181 AVENUE PIERRE BROSSOLETTE, MONTROUGE, I0
Market cap: $569.3M (2/09/2026)
Price: $23.80
Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing
Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
Announces Appointment of Philina Lee, Ph.D. to Board of Directors
Earnings Release
Announces Resignation of Board Member
Establishes an At-The-Market (ATM) Program on Nasdaq
Reports Second Quarter and Half-Year 2025 Financial Results
Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers
Q3
Q2
Amended Annual Report
FY 2024
Notice of Late Filing for Annual Report
Q1
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Notice of Exempt Offering of Securities
PRE 14A
Definitive Proxy Statement
Additional Proxy Materials
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Amended Schedule 13G - Ownership Report